News
Company News Press Release Announcements |
On August 3, the NMPA approved the marketing of Rabeprazole Sodium Enteric-coated Tablets developed by Shanxiang Pharmaceutical, a subsidiary of Qingfeng Pharmaceutical Group. This is the second pr...
2023-08-07
Recently, Tedizolid Phosphate for Injection, a drug developed by Qingfeng Pharmaceutical for the treatment of acute bacterial skin and skin soft tissue infections, was officially approved for marke...
2023-04-26
Recently, the "Smooth Anti-Inflammation and Easy Breathing" - Chinese and Western Integration Summit Forum on Respiratory Infectious Diseases·Tianjin Station hosted by Qingfeng Pharmaceutical came ...
2023-04-23
On August 10, lacosamide oral solution (trade name: Xinkang®) developed by Qingfeng Pharmaceutical was officially approved for marketing by the NMPA.
2022-08-19
A few days ago, the official website of the NMPA released the drug approval certificate. The information showed on March 22, the Lenvatinib capsule developed by Hangzhou Qingyue and Shanxiang pharm...
2022-04-01
07/23
2020
The first generic of Esomeprazole Magnesium Enteric-coated Tablets was approved for marketing, which is deemed to pass consistency evaluation. A few days ago, Esomeprazole Magnesium Enteric-coated ...
05/19
2020
Recently, Jiangxi Qingfeng Pharmaceutical'sapplication for Apixaban tablets (acceptance number CYHS1800008) submittedunder the generic category 4 was approved, and the approval number was H20203204...
05/23
2018
China Jiangxi Net News On May 21, the reporter learned from the Jiangxi Food and Drug Administration that the two formulations of Entecavir (trade name: Weiliqing) dispersible tablets and capsules...
05/09
2017
On April 7th, at the Qingfeng Pharmaceutical Valley Hangzhou Investment Promotion Conference held in Ganzhou City, Qingfeng Pharmaceutical Group and Zhejiang University signed a cooperation agreeme...
12/22
2016
From January to September this year, the main business income exceeded 2.7 billion CNY, and the tax revenue exceeded 500 million CNY. In the past five years, the annual average investment of 150...
04/24
2019
To ensure the safety of enterprises, society and people’s lives and property, prevent the occurrence of sudden environmental pollution accidents, and quickly and effectively control and deal with ...
07/02
2018
According to the "Guidelines for Accounting Methods and Reporting of Greenhouse Gas Emissions by Enterprises in Other Industries (for Trial Implementation)" issued by the National Development and ...
|
|
Qingfeng Pharmaceutical Group Co.Ltd
Location：8 Zhandong Av., Zhanggong, Ganzhou, Jiangxi Province, China
Phone：+86-0797-5560800,5560600
Fax: +86-0797-5560620